PMID- 32850310 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200928 IS - 2234-943X (Print) IS - 2234-943X (Electronic) IS - 2234-943X (Linking) VI - 10 DP - 2020 TI - Circular RNA 103862 Promotes Proliferation and Invasion of Laryngeal Squamous Cell Carcinoma Cells Through the miR-493-5p/GOLM1 Axis. PG - 1064 LID - 10.3389/fonc.2020.01064 [doi] LID - 1064 AB - Accumulating evidence suggests that circular RNAs (circRNAs) may be a key contributor to oncogenesis. Yet, the function of circRNAs in laryngeal squamous cell carcinoma (LSCC) is still not clear. In this study, we examined the function of circRNA_103862 in LSCC progression by analyzing the tissue specimens collected from a patient with LSCC by using different LSCC cell models in vitro and an LSCC xenograft model in nude mice. We found that circRNA_103862 was frequently upregulated in the tissues of LSCC and was correlated with metastasis and prognosis of LSCC patients. Furthermore, circRNA_103862 downregulation could reduce proliferation, migration, and invasion ability of LSCC cells. In terms of mechanism exploration, miR-493-5p was sponged by circRNA_103862. Rescue experiments also showed that circRNA_103862 could achieve a carcinogenic effect by regulating miR-493-5p. Moreover, a luciferase reporter analysis showed that Golgi membrane protein 1 (GOLM1) is a downstream effector of miR-493-5p. In conclusion, our data suggested that circRNA_103862 promotes the proliferation of LSCC through targeting the miR-493-5p/GOLM1 axis, and it might serve as a potential prognosis marker and therapy target for LSCC. CI - Copyright (c) 2020 Wang, Wu, Wang, Yang, Li, Wang, Zhao, Zhang, Liu, Cao, Tian, Yu and Sun. FAU - Wang, Xin AU - Wang X AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. FAU - Wu, Tianyi AU - Wu T AD - Department of Otorhinolaryngology, Head and Neck Surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, China. FAU - Wang, Peng AU - Wang P AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. FAU - Yang, Like AU - Yang L AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. FAU - Li, Qiuying AU - Li Q AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. FAU - Wang, Jingting AU - Wang J AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. FAU - Zhao, Rui AU - Zhao R AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. FAU - Zhang, Jiarui AU - Zhang J AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. FAU - Liu, Ming AU - Liu M AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. FAU - Cao, Jing AU - Cao J AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. FAU - Tian, Linli AU - Tian L AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. FAU - Yu, Boyu AU - Yu B AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. FAU - Sun, Yanan AU - Sun Y AD - Department of Otolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China. LA - eng PT - Journal Article DEP - 20200729 PL - Switzerland TA - Front Oncol JT - Frontiers in oncology JID - 101568867 PMC - PMC7405723 OTO - NOTNLM OT - GOLM1 OT - LSCC OT - circRNA_103862 OT - circular RNA OT - miR-493-5p EDAT- 2020/08/28 06:00 MHDA- 2020/08/28 06:01 PMCR- 2020/01/01 CRDT- 2020/08/28 06:00 PHST- 2020/02/24 00:00 [received] PHST- 2020/05/28 00:00 [accepted] PHST- 2020/08/28 06:00 [entrez] PHST- 2020/08/28 06:00 [pubmed] PHST- 2020/08/28 06:01 [medline] PHST- 2020/01/01 00:00 [pmc-release] AID - 10.3389/fonc.2020.01064 [doi] PST - epublish SO - Front Oncol. 2020 Jul 29;10:1064. doi: 10.3389/fonc.2020.01064. eCollection 2020.